New Zealand markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
104.74+0.07 (+0.07%)
At close: 04:00PM EDT
104.45 -0.29 (-0.28%)
After hours: 07:50PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 182.09B
Enterprise value 190.02B
Trailing P/E 32.61
Forward P/E 22.52
PEG ratio (5-yr expected) 5.70
Price/sales (ttm)4.54
Price/book (mrq)4.69
Enterprise value/revenue 4.20
Enterprise value/EBITDA 17.16

Trading information

Stock price history

Beta (5Y monthly) 0.75
52-week change 3-4.64%
S&P500 52-week change 326.27%
52-week high 3121.64
52-week low 389.67
50-day moving average 3111.26
200-day moving average 3106.46

Share statistics

Avg vol (3-month) 35.63M
Avg vol (10-day) 34.96M
Shares outstanding 51.74B
Implied shares outstanding 61.74B
Float 81.73B
% held by insiders 10.54%
% held by institutions 176.56%
Shares short (30 Apr 2024) 414.48M
Short ratio (30 Apr 2024) 42.74
Short % of float (30 Apr 2024) 40.84%
Short % of shares outstanding (30 Apr 2024) 40.83%
Shares short (prior month 28 Mar 2024) 414.48M

Dividends & splits

Forward annual dividend rate 42.2
Forward annual dividend yield 42.10%
Trailing annual dividend rate 32.12
Trailing annual dividend yield 32.03%
5-year average dividend yield 41.60
Payout ratio 464.80%
Dividend date 315 May 2024
Ex-dividend date 412 Apr 2024
Last split factor 210000:4798
Last split date 302 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.96%
Operating margin (ttm)15.40%

Management effectiveness

Return on assets (ttm)6.09%
Return on equity (ttm)14.76%

Income statement

Revenue (ttm)40.33B
Revenue per share (ttm)23.18
Quarterly revenue growth (yoy)2.20%
Gross profit (ttm)N/A
EBITDA 10.37B
Net income avi to common (ttm)5.61B
Diluted EPS (ttm)3.21
Quarterly earnings growth (yoy)-7.10%

Balance sheet

Total cash (mrq)6.65B
Total cash per share (mrq)3.82
Total debt (mrq)14.71B
Total debt/equity (mrq)37.66%
Current ratio (mrq)1.60
Book value per share (mrq)22.31

Cash flow statement

Operating cash flow (ttm)7.14B
Levered free cash flow (ttm)4.61B